Furethidine
Appearance
Clinical data | |
---|---|
Other names | ethyl 4-phenyl-1-(2-tetrahydrofurfuryloxyethyl)piperidine-4-carboxylate |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.017.451 |
Chemical and physical data | |
Formula | C21H31NO4 |
Molar mass | 361.482 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Furethidine[1] is a 4-phenylpiperidine derivative that is related to the clinically used opioid analgesic drug pethidine (meperidine).[2]
Furethidine is not currently used in medicine and is a Class A/Schedule I drug which is controlled under UN drug conventions. It has similar effects to other opioid derivatives, such as analgesia, sedation, nausea and respiratory depression.[3] In the United States it is a Schedule I Narcotic controlled substance with the ACSCN of 9626.[4]
References
- ^ GB Patent 797448
- ^ Maul C, Buschmann H, Sundermann B. Opioids: 3.3 Synthetic Opioids. Analgesics 2005; 159-169. ISBN 978-3-527-30403-5
- ^ Cahal DA, Dare JG, Keith D. A Sequential Trial of Analgesics in Labour. International Journal of Obstetrics and Gynaecology 1961; 68(1): 88–93.
- ^ http://www.deadiversion.usdoj.gov/schedules/orangebook/d_cs_drugcode.pdf, pp. 13, accessed 23. January 2016